Healthcare · Revenue & Growth
The Best AI Workflow for Revenue Operations in Medical Devices
We design, build, and run AI-native revenue operations for medical device manufacturers, field service leaders, quality teams, and commercial operations. This page describes the engagement: scope, pricing, timeline, controls, and the KPIs we commit to.
Early access: we work with a small first cohort. Engagements are scoped, priced, and shipped end-to-end by our team — not referred to third parties.
In one sentence
AI-native revenue operations for medical devices is a phased engagement (Discovery 3 weeks → Build 8 weeks → Run continuous (regulated industry)) that ships a production workflow on top of QMS and CRM, moves forecast accuracy by −77% against the medical devices baseline, and is operated under revenue & growth governance from day one.
Key facts
- Industry
- Medical Devices
- Use case
- Revenue Operations
- Intent cluster
- Revenue & Growth
- Primary KPI
- forecast accuracy, CRM completeness, stage conversion, and sales productivity
- Top benchmark
- Cost per qualified meeting: $420 → $95 (−77%)
- Systems integrated
- QMS, CRM, field service platforms
- Buyer
- medical device manufacturers, field service leaders, quality teams, and commercial operations
- Risk lens
- quality management, clinical claims, product support, training accuracy, and complaint handling
- Engagement timeline
- Discovery 3 weeks → Build 8 weeks → Run continuous (regulated industry)
- Team size
- 2 senior delivery + 1 part-time reviewer trainer
- Discovery price
- $5k · 2-week sprint
- Build price
- $15k–$22k · 6-8 weeks
Primary outcome
make revenue data cleaner, faster, and easier to act on
What we ship
CRM hygiene workflows, forecasting assistant, pipeline inspection, and operating cadence
KPIs we report on
forecast accuracy, CRM completeness, stage conversion, and sales productivity
Why Medical Devices teams hire us for this
The instinct in medical devices is to either build everything internally or sign a multi-year retainer with a consulting firm. Neither option is well-matched to the speed of model and tooling changes in 2026. A scoped, phased AI-native engagement on revenue operations lets you move fast on the build while keeping option value on what comes next.
Recent industry benchmarks (Gartner, Salesforce Research) show medical devices revenue teams spend 60-70% of their week on non-selling activities. AI-native delivery targets that non-selling block first.
Industry context: Mid-market and enterprise operators face the same fundamental tradeoff: AI must compress operational cycle time while remaining auditable and integrable with existing systems of record.
Benchmarks we hit
Reference benchmarks from production deployments of revenue operations in medical devices-comparable contexts. Sources noted per row. Your actuals are measured against the baseline captured in Discovery.
| Metric | Industry baseline | AI-native typical | Delta |
|---|---|---|---|
Cost per qualified meeting Includes AI infra cost, SDR time, and overhead allocation | $420 | $95 | −77% |
Lead-to-meeting cycle time Median across Salesforce-reporting B2B teams; AI-native compression validated on first thin-slice deployment | 11.4 days | 2.8 days | −75% |
Outbound reply rate Industry baseline from Gartner B2B Sales Pulse; AI-native lift from per-prospect context injection | 1.2% | 4.1% | +3.4× |
Benchmarks are reference values from comparable engagements and authoritative sector benchmarks. Your engagement's baseline is captured during Discovery and actuals are reported weekly during Run against that baseline.
How we operate the workflow
own process design, approve forecast logic, manage incentives, and arbitrate edge cases. That sentence drives the architecture. Every step the model can do safely, it does. Every step that requires judgment routes to a named human owner with a logged decision. For medical devices workflows where the risk includes quality management, clinical claims, product support, training accuracy, and complaint handling, this is the line between a demo and a defensible production system.
What we build inside the workflow
The Build deliverable for revenue operations in medical devices is not a model — it is an operating system around a model. The model is the cheap part (Claude or GPT-4-class, swappable). The operating system — eval harness, reviewer queue, audit log, governance map, runbook — is the expensive part, and the part that determines whether the workflow survives the second quarter of production.
Reference architecture
4-layer AI-native workflow for revenue & growth
Source intake → AI orchestration → Action → Human review & quality.See the full architecture diagram for Revenue & Growth →
AI-native vs traditional approach
How a scoped AI-native engagement compares to the traditional alternatives for revenue operations in medical devices.
| Dimension | Traditional (in-house build or BPO) | AI-native engagement (us) |
|---|---|---|
| Time to production | 6-12 months | 6-10 weeks (thin slice) |
| Pricing model | FTE hourly retainer or fixed staffing | Phased fixed-price (Discovery → Build → opt Run) |
| Audit / governance | Manual logs, periodic review | Versioned prompts, audit logs, reviewer queues, attestations |
| Operator throughput lift | 1.0× (baseline) | −75% |
| Cost per unit | Industry baseline | AI-native engagements deliver thin-slice production in 6-8 weeks with measurable baseline-vs-actuals reporting. |
| Exit path | Multi-quarter notice + knowledge loss | Month-to-month Run, full handover plan in Build SoW |
Traditional process automation projects cost $80-200k+ with 6-12 month payback; AI-native engagements deliver thin-slice production in 6-8 weeks with measurable baseline-vs-actuals reporting.
Engagement scope & pricing
We run this as a fixed-scope engagement with a clear commercial envelope, not an open-ended retainer.
Revenue engagement
Three phases, billed separately. You commit one phase at a time.
Phase 1 · Discovery
$5k
2-week sprint
Phase 2 · Build
$15k–$22k
6-8 weeks
Phase 3 · Run
$2k–$3k / mo
optional, hourly bank also available
~$25k–$45k typical year 1 (60% take the run option for ~6 months)
Outbound, growth, or revenue-ops workflow, integration with your CRM, weekly operating review during Run.
Discovery is the only commitment to start. After Discovery, we scope Build with a fixed price. Run is opt-in, month-to-month, no lock-in.
The 4-phase delivery model
Phase 1 · Weeks 1–2
Discovery
We map the workflow, the systems, the decisions, and the baseline metrics. Output: a scoped statement of work.
Phase 2 · Weeks 2–4
Design
We design the operating model: data access, retrieval, prompts, review queues, controls, and the KPI dashboard.
Phase 3 · Weeks 4–8
Build
We ship a production thin slice on real data, with versioned prompts, evaluation harness, and human review.
Phase 4 · Weeks 8+
Run
We run the workflow with you weekly, expand into adjacent work, and report against baseline.
Interactive ROI calculator
Estimate your AI-native ROI for revenue operations
Reference inputs below are typical for medical devices teams in the revenue cluster. Adjust them to match your situation.
Projected
Current monthly cost
$24,000
AI-native monthly cost
$7,920
Annual savings
$192,960
67% cost reduction · ~468 operator-hours freed / month
Governance and risk controls
Most "AI governance" frameworks medical devices teams encounter are slide decks. Ours is a runtime: every inference call passes through guardrails (input filters, output validators, schema enforcement), every action is logged with the prompt and model version that produced it, every reviewer decision is captured. The framework documents what the runtime already enforces.
How we report ROI
Compounding is the under-rated ROI driver on revenue operations. Week 1 of Run delivers the obvious gain — model handles the routine. By month 3, the prompt library, source corpus, and reviewer playbook are tuned to your specific medical devices workflow. By month 6, the gap between your workflow and a generic AI agent is what makes the system hard to replace, internally or externally.
Common pitfall & mitigation
The failure mode we see most often on AI-native revenue operations engagements in medical devices contexts.
Attribution loss
AI-generated touches blur the funnel; nobody knows what really worked
UTM convention + touch-level logging from day 1; weekly cohort analysis in the Run review
Build internally or work with us
The opportunity cost of building first in medical devices is often invisible: 6-9 months spent hiring, tooling, and converging on a reference architecture is 6-9 months of competitors shipping. The engagement model we propose front-loads the reference architecture and the senior delivery team, then transitions the operation to your team once the pattern is proven.
What to ask us before signing
- Ask for a workflow map that shows intake, retrieval, generation, review, escalation, system updates, and measurement.
- Ask for an evaluation plan using real examples from medical devices, not only generic test prompts.
- Ask how we will move forecast accuracy, CRM completeness, stage conversion, and sales productivity within the first 30 to 60 days.
- Ask which parts of the process remain human-owned and why.
- Ask for our exit plan: what stays with you if the engagement ends.
Recommended first project
The best first project for AI-native revenue operations in medical devices is a contained workflow with enough volume to matter and enough structure to evaluate. Avoid the most politically sensitive process first. Avoid a workflow with no measurable baseline. Choose a process where we can ship a production-grade thin slice, prove adoption, and then extend the same architecture to neighboring work.
A practical target is a 30-day build followed by a 60-day operating period. In the first 30 days, we map the work, connect the minimum data sources, build the assistant, and create the review process. In the next 60 days, the system handles real volume, the team measures outcomes, and we improve the workflow weekly. By day 90, leadership knows whether to expand into adjacent work.
Frequently asked questions
How do you automate revenue operations in medical devices with AI?+
We map the existing revenue operations workflow inside medical devices, identify the high-volume, high-structure tasks, and build an AI agent that handles those tasks while routing low-confidence cases to a human reviewer. The build connects to your QMS, CRM, field service platforms, runs against a labelled test set, and ships behind a reviewer queue before it sees production traffic. We then operate it, measure forecast accuracy, CRM completeness, stage conversion, and sales productivity, and improve it weekly.
What does it cost to automate revenue operations for a medical devices company?+
Three phases, billed separately. Discovery sprint: $5k (2-week sprint). Build engagement: $15k–$22k (6-8 weeks). Run retainer: $2k–$3k / mo (optional, hourly bank also available). ~$25k–$45k typical year 1 (60% take the run option for ~6 months). Outbound, growth, or revenue-ops workflow, integration with your CRM, weekly operating review during Run.
What is the best AI agent for revenue operations in medical devices?+
There is no single "best" off-the-shelf agent for revenue operations in medical devices — the right architecture depends on your QMS setup, your data, and your risk profile. We typically combine a frontier LLM (Claude, GPT-4-class, or Gemini) with a retrieval layer over your approved sources, tool-use for QMS and CRM integrations, and a reviewer queue. We benchmark candidate models against a labelled test set during Discovery and pick the one with the best accuracy/cost ratio for your workflow.
How long does it take to deploy AI revenue operations for medical devices?+
A thin-slice deployment in 2-week sprint after Discovery, with real medical devices data and real reviewers. The full Build phase runs 6-8 weeks. By day 90, forecast accuracy, CRM completeness, stage conversion, and sales productivity is instrumented, the team has a baseline, and leadership has the data needed to decide on expansion into adjacent medical devices workflows.
What do we own, and what do you own?+
We own the workflow design, the prompts, the retrieval architecture, the evaluation harness, and weekly improvement. Your medical device manufacturers, field service leaders, quality teams, and commercial operations team owns data access, policy, exception approval, and final commercial decisions. At the end of the engagement, every prompt, eval, and config is handed over — no lock-in.
How do you measure revenue impact for revenue operations in medical devices?+
We instrument forecast accuracy, CRM completeness, stage conversion, and sales productivity from day one, paired with sector-level metrics such as service resolution time, training completion, complaint cycle time, and rep productivity. We report against baseline weekly during Run, and we publish a 90-day impact recap.
Sources we reference
The following sources inform the architecture, governance, and benchmarks we apply on medical devices engagements. Cited here so you can verify and dig deeper.
- FDA Digital Health
- Worldwide AI and Generative AI Spending Guide — IDC
- Hype Cycle for Artificial Intelligence — Gartner
- Generative AI Impact on Marketing & Sales — McKinsey
- B2B Sales Pulse Survey — Gartner for Sales
- Google Search Central: helpful, reliable, people-first content
- Google Search Central: URL structure best practices
Start the engagement
Book a discovery call for Medical Devices
Tell us about your workflow, the systems involved, and the KPI you want to move. We'll send a scoped statement of work within 5 business days.